Gerd R. Burmester et al <br/><br/>
Long-Term Safety of Adalimumab in 29,967 Adult Patients From Global Clinical Trials Across Multiple Indications: An Updated Analysis 

<br/><br/><label>Subjects--Topical Terms: </label><br/>Computer science, information & general works